(S)-N-(1-(2,6-dichlorophenyl)ethyl)-3-(2-methylpyridin-4-yl)-1H-indazole-5-carboxamide

ID: ALA3798624

Chembl Id: CHEMBL3798624

PubChem CID: 127046585

Max Phase: Preclinical

Molecular Formula: C22H18Cl2N4O

Molecular Weight: 425.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H](C)c4c(Cl)cccc4Cl)cc23)ccn1

Standard InChI:  InChI=1S/C22H18Cl2N4O/c1-12-10-14(8-9-25-12)21-16-11-15(6-7-19(16)27-28-21)22(29)26-13(2)20-17(23)4-3-5-18(20)24/h3-11,13H,1-2H3,(H,26,29)(H,27,28)/t13-/m0/s1

Standard InChI Key:  SVZFHBDBECKIKZ-ZDUSSCGKSA-N

Alternative Forms

  1. Parent:

    ALA3798624

    ---

Associated Targets(Human)

MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.32Molecular Weight (Monoisotopic): 424.0858AlogP: 5.73#Rotatable Bonds: 4
Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.21CX Basic pKa: 4.37CX LogP: 4.67CX LogD: 4.67
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.44Np Likeness Score: -1.39

References

1. Li L, Liu F, Jin N, Tang S, Chen Z, Yang X, Ding J, Geng M, Jiang L, Huang M, Cao J..  (2016)  Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).,  26  (11): [PMID:27106711] [10.1016/j.bmcl.2016.04.029]

Source